Table 4 Univariate analyses of TGFBI methylation in prostate cancer patients
Variable | Methylation status | P-value | |
|---|---|---|---|
| Â | Absent | Present | Â |
Gleason score | Â | Â | 0.6241 |
   6 | 2 (16.7%) | 10 (83.3%) |  |
   7 (3+4) | 6 (25.0%) | 18 (75.0%) |  |
   7 (4+3) | 1 (8.3%) | 11 (91.7%) |  |
   9 | 0 (0.0%) | 1 (100.0%) |  |
Extracapsular extension | Â | Â | 0.8840 |
   Negative | 8 (20.0%) | 32 (80.0%) |  |
   Positive | 1 (11.1%) | 8 (88.9%) |  |
Seminal vesicle involvement | Â | Â | 0.5582 |
   Negative | 7 (16.7%) | 35 (83.3%) |  |
   Positive | 1 (16.7%) | 5 (83.3%) |  |
Prostatectomy margin positivity | Â | Â | 0.4364 |
   Negative | 8 (23.5%) | 26 (76.5%) |  |
   Positive | 1 (6.7%) | 14 (93.3%) |  |
Regional lymph node involvement | Â | Â | 0.3975 |
   Negative | 7 (18.4%) | 31 (81.6%) |  |
   Positive | 0 (0.0%) | 1 (100.0%) |  |